Detalles de la búsqueda
1.
Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy.
Blood
; 137(2): 216-231, 2021 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33024998
2.
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results.
Blood
; 135(15): 1204-1213, 2020 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31876911
3.
Post-relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation.
Hematol Oncol
; 40(1): 48-56, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34763367
4.
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.
J Allergy Clin Immunol
; 146(2): 356-366.e4, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32437738
5.
Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 26(6): 1099-1105, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32165327
6.
Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia.
Blood
; 132(15): 1568-1572, 2018 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30111609
7.
Identifying risk factors for depression and anxiety symptoms in patients with chronic lymphocytic leukemia.
Support Care Cancer
; 28(4): 1799-1807, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31332513
8.
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(12): 2305-2321, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446199
9.
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.
N Engl J Med
; 374(26): 2530-41, 2016 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27355533
10.
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.
N Engl J Med
; 374(4): 323-32, 2016 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-26641137
11.
Illness Perceptions in Chronic Lymphocytic Leukemia: Testing Leventhal's Self-regulatory Model.
Ann Behav Med
; 53(9): 839-848, 2019 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30590383
12.
A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor.
Br J Haematol
; 180(2): 259-266, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29193006
13.
A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.
Haematologica
; 103(8): 1351-1358, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29748443
14.
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.
Br J Haematol
; 176(4): 618-628, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27977057
15.
Cardio-Oncology: A Win-Win Situation: How Solving the Mystery of an Ibrutinib Off-Target Effect Reveals New Insights Into Atrial Fibrillation Mechanisms.
Circulation
; 142(25): 2456-2458, 2020 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33347329
16.
Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 22(12): 2117-2125, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27660167
17.
Phase Ib trial of the PI3K/mTOR inhibitor voxtalisib (SAR245409) in combination with chemoimmunotherapy in patients with relapsed or refractory B-cell malignancies.
Br J Haematol
; 175(1): 55-65, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27293194
18.
A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia.
Blood
; 123(9): 1302-8, 2014 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24381226
19.
PKC-ß as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL.
Blood
; 124(9): 1481-91, 2014 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25001469
20.
A phase 1 clinical trial of flavopiridol consolidation in chronic lymphocytic leukemia patients following chemoimmunotherapy.
Ann Hematol
; 95(7): 1137-43, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118540